Shkreli Loses Bid To Nix Charges After Resting Case
By Stewart Bishop · July 26, 2017, 7:00 PM EDT
Attorneys for former Turing Pharmaceuticals and Retrophin CEO Martin Shkreli on Wednesday rested their case without calling any witnesses to testify at his securities fraud trial over allegations he defrauded investors...
To view the full article, register now.